Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Beximco Pharmaceuticals Limited
BXPBeximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh. Address: 19 Dhanmondi R/A, Dhaka, Bangladesh, 1205
Analytics
Objectif de Cours de WallStreet
11 434.12 GBXRatio C/B
3.875Rendement du dividende
9.2 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés BXP
Analyse des dividendes BXP
Croissance des dividendes sur 5 ans
45 %Croissance continue
–Ratio de distribution Moyenne sur 5 ans
39 %Historique des dividendes BXP
Valorisation des titres BXP
financières BXP
Résultats | 2019 | Dynamique |